Source disclosure: February 09, 2026
Eisai Co., Ltd. [4523.T]
TOKYO — Eisai Co., Ltd. (4523), a leading pharmaceutical company, announced its consolidated earnings for the third quarter of the fiscal year ending March 2026 on February 9, 2026. The company reported a total revenue of 619.95 billion yen, marking a 3.1% increase from the same period last year. However, the operating income decreased by 1.7%, and the net income attributable to owners fell by 8.1%. Despite these declines, Eisai's basic earnings per share stood at 148.31 yen.
The company also provided an overview of its financial position as of December 31, 2025. Total assets amounted to 1,486.22 billion yen, while shareholders' equity reached 915.66 billion yen. This represents a slight improvement over the previous fiscal year-end figures. Additionally, the company disclosed that it will maintain its interim dividend payout of 80 yen per share for the first half of the current fiscal year, aligning with its commitment to shareholder returns despite the challenging market conditions.
Eisai further outlined its full-year forecast for the fiscal year ending March 2026. The company anticipates a modest growth in sales revenue of 790 billion yen, up slightly by 0.1% compared to the prior fiscal year. Operating profit is expected to rise marginally by 0.2%, but pre-tax income and net income are projected to decline by 3.4% and 10.6%, respectively. Basic earnings per share are forecasted to be 147.20 yen, reflecting the ongoing challenges faced by the industry.
In addition to these financial updates, Eisai plans to host an investor briefing for institutional investors and analysts on February 9, 2026. The presentation materials will subsequently be made available on the company’s website. Eisai has emphasized the importance of considering various factors that could impact future performance and noted that actual results may differ significantly due to unforeseen circumstances. Investors are advised to review the detailed notes included in the quarterly report for a comprehensive understanding of the assumptions underlying the forecasts.
AI-translated content. 🟢 Confidence: High See terms • Original filing